Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Resorbable Orthopedic Products (ROP), a subsidiary of Wound Management Technologies, has entered into a license agreement with BioStructures to develop products for bone remodeling in the human skeletal system based on ROP' patent.
Subscribe to our email newsletter
As per the agreement, ROP has received initial $100K licensing fee from BioStructures and will also receive an additional license fees as well as royalties on sales throughout the life of the patent.
BioStructures CEO Russell Cook said this transaction allows them to combine their portfolio of proprietary biomaterials with a patented resorbable wax carrier.
Wound Management Technologies president Deborah Hutchinson said they are pleased to have reached a license agreement with BioStructures to develop many of the orthopedic products related to ROP’ patent on resorbable bone wax and bone void fillers.
"This agreement is the first commercial agreement for our subsidiary ROP and marks the start of a second product line for WNDM," Hutchinson said.